ResearcherFujian Medical UniversityNo recent work listed

Jianyuan Song

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4987-4975; OpenAlex author ID A5031913917. Sources: OpenAlex.

Their work

Papers: 2 (first author 1, last author 0)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: 1 paper

Papers 2

The benefit of adjuvant radiotherapy on overall survival in resected stage I to II pancreatic cancer: A propensity-adjusted analysis. First author DOI 10.1371/journal.pone.0243170 ↗
Combined pretreatment serum CA19-9 and neutrophil-to-lymphocyte ratio as a potential prognostic factor in metastatic pancreatic cancer patients. Co-author DOI 10.1097/md.0000000000009707 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Benhua Xu · 2 shared papers, 2018–2020 · strength 0.24
- Paper The benefit of adjuvant radiotherapy on overall survival in resected stage I to II pancreatic cancer: A propensity-adju… DOI 10.1371/journal.pone.0243170 ↗
- Paper Combined pretreatment serum CA19-9 and neutrophil-to-lymphocyte ratio as a potential prognostic factor in metastatic pa… DOI 10.1097/md.0000000000009707 ↗
Zhuangbin Lin · 1 shared paper, 2020 · strength 0.13
- Paper The benefit of adjuvant radiotherapy on overall survival in resected stage I to II pancreatic cancer: A propensity-adju… DOI 10.1371/journal.pone.0243170 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.